Following the news that Ionis Pharmaceuticals Inc (NASDAQ: IONS) has secured FDA approval in a major way for its pipeline drug Spinraza in the indication …
In a research report issued Tuesday, Leerink Swann analyst Paul Matteis initiated coverage on shares of Cempra Inc (NASDAQ:CEMP), with a Market Perform …
